{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:13:16Z","timestamp":1785265996212,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clinbiochem.2023.110596","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T22:30:26Z","timestamp":1686177026000},"page":"110596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-2638","authenticated-orcid":false,"given":"Tianhua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Bellai-Dussault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-2949","authenticated-orcid":false,"given":"Danna","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7854-4257","authenticated-orcid":false,"given":"Heather","family":"Howley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Reszel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1686-2057","authenticated-orcid":false,"given":"Nan","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley D.","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6653","key":"10.1016\/j.clinbiochem.2023.110596_b0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down's syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110596_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/096914130301000302","article-title":"Maternal serum screening in Ontario using the triple marker test","volume":"10","author":"Summers","year":"2003","journal-title":"J Med Screen."},{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110596_b0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/pd.2084","article-title":"Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center","volume":"28","author":"Okun","year":"2008","journal-title":"Prenat Diagn."},{"issue":"354","key":"10.1016\/j.clinbiochem.2023.110596_b0020","article-title":"Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units","volume":"4","author":"Chitty","year":"2016","journal-title":"BMJ."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110596_b0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/pd.5563","article-title":"A 2-year review of publicly funded cell-free DNA screening in Ontario: utilization and adherence to funding criteria","volume":"40","author":"Bellai-Dussault","year":"2020","journal-title":"Prenat Diagn."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110596_b0030","first-page":"56","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen."},{"issue":"7","key":"10.1016\/j.clinbiochem.2023.110596_b0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-\u03b2 human chorionic gonadotrophin, placental growth factor, and \u03b1-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat Diagn."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.AOG.0000263470.89007.e3","article-title":"First- and second-trimester evaluation of risk for Down syndrome","volume":"110","author":"Ball","year":"2007","journal-title":"Obstet Gynecol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110596_b0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/uog.17283","article-title":"Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13","volume":"49","author":"Santorum","year":"2017","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110596_b0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/uog.14811","article-title":"Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"45","author":"Tsiakkas","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/uog.14809","article-title":"Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"46","author":"Bredaki","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/uog.14870","article-title":"Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"46","author":"Wright","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/uog.14869","article-title":"Serum free \u03b2-human chorionic gonadotropin in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"46","author":"Wright","year":"2015","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110596_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/uog.5332","article-title":"First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics","volume":"31","author":"Kagan","year":"2008","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0969141313486893","article-title":"Allowing for ethnic group in antenatal screening for Down\u2019s syndrome","volume":"20","author":"Bestwick","year":"2013","journal-title":"J Med Screen."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110596_b0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pd.2755","article-title":"Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters","volume":"31","author":"Zhang","year":"2011","journal-title":"Prenat Diagn."},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110596_b0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1258\/jms.2008.008049","article-title":"First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency","volume":"15","author":"Bestwick","year":"2008","journal-title":"J Med Screen."},{"issue":"10","key":"10.1016\/j.clinbiochem.2023.110596_b0090","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pd.994","article-title":"Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus","volume":"24","author":"Huttly","year":"2004","journal-title":"Prenat Diagn."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110596_b0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pd.4722","article-title":"Insulin dependent diabetes mellitus (IDDM) and first trimester markers in prenatal screening for Down syndrome","volume":"36","author":"Huttly","year":"2016","journal-title":"Prenat Diagn."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/pd.1970140112","article-title":"Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome","volume":"14","author":"Palomaki","year":"1994","journal-title":"Prenat Diagn."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110596_b0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/pd.5052","article-title":"Nuchal translucency measurement, free \u03b2-hCG and PAPP-A concentrations in IVF\/ICSI pregnancies: systematic review and meta-analysis","volume":"37","author":"Cavoretto","year":"2017","journal-title":"Prenat Diagn."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110596_b0110","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jogc.2018.02.024","article-title":"Comparing Maternal Serum Screening Markers Among IVF and Spontaneous Conceptions in Ontario Through Registry Data","volume":"40","author":"Lanes","year":"2018","journal-title":"J Obstet Gynaecol Can."},{"issue":"9","key":"10.1016\/j.clinbiochem.2023.110596_b0115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pd.1791","article-title":"The impact of bias in MoM values on patient risk and screening performance for Down syndrome","volume":"27","author":"Nix","year":"2007","journal-title":"Prenat Diagn."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110596_b0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000336252","article-title":"Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9\u201313 weeks' gestation in screening for aneuploidies","volume":"31","author":"Ball","year":"2012","journal-title":"Fetal Diagn Ther."},{"issue":"oct29 1","key":"10.1016\/j.clinbiochem.2023.110596_b0125","doi-asserted-by":"crossref","first-page":"b4347","DOI":"10.1136\/bmj.b4347","article-title":"Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study","volume":"339","author":"Shipton","year":"2009","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110596_b0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pd.4053","article-title":"Accuracy of self-reported smoking status in first trimester aneuploidy screening","volume":"33","author":"Spencer","year":"2013","journal-title":"Prenat Diagn."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110596_b0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/pd.72","article-title":"Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?","volume":"21","author":"Sancken","year":"2001","journal-title":"Prenat Diagn."},{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110596_b0140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/pd.719","article-title":"Strict glycemic control in diabetic pregnancy-implications for second-trimester screening for Down syndrome","volume":"23","author":"Peled","year":"2003","journal-title":"Prenat Diagn."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110596_b0145","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.fertnstert.2016.07.1120","article-title":"Maternal serum screening markers and nuchal translucency measurements in in vitro fertilization pregnancies: a systematic review","volume":"106","author":"Lanes","year":"2016","journal-title":"Fertil Steril."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110596_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1471-0528.1992.tb14392.x","article-title":"Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: Implications for screening for Down's syndrome","volume":"99","author":"Wald","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110596_b0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","article-title":"Antenatal screening for Down's syndrome","volume":"4","author":"Wald","year":"1997","journal-title":"J Med Screen."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110596_b0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-0528.1979.tb10575.x","article-title":"Maternal serum alpha-fetoprotein and diabetes mellitus","volume":"86","author":"Wald","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.clinbiochem.2023.110596_b0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pd.440","article-title":"Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance","volume":"22","author":"Rudnicka","year":"2002","journal-title":"Prenat Diagn."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110596_b0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1258\/jms.2009.009028","article-title":"Adjustment of serum markers in first trimester screening","volume":"16","author":"Lambert-Messerlian","year":"2009","journal-title":"J Med Screen."},{"issue":"10","key":"10.1016\/j.clinbiochem.2023.110596_b0175","doi-asserted-by":"crossref","first-page":"e46955","DOI":"10.1371\/journal.pone.0046955","article-title":"George LM and Huttly W J Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests","volume":"7","author":"Wald","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.clinbiochem.2023.110596_b0180","unstructured":"Better Outcomes Registry & Network. https:\/\/www.bornontario.ca\/en\/index.aspx. Accessed Dec. 10 2020."},{"key":"10.1016\/j.clinbiochem.2023.110596_b0185","doi-asserted-by":"crossref","unstructured":"Lanes A, Fell DB, Teitelbaum M, Sprague AE, Johnson M, Wang H, Elliott M, Guo Y, Meng L, Yuzpe A, Bissonnette F, Leveille MC, Walker MC. CARTR Plus: the creation of an ART registry in Canada. Hum Reprod Open. 2020 Jun 6;2020(3):hoaa022. doi: 10.1093\/hropen\/hoaa022. PMID: 32529049; PMCID: PMC7275630.","DOI":"10.1093\/hropen\/hoaa022"},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110596_b0190","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/(SICI)1097-0223(199808)18:8<842::AID-PD339>3.0.CO;2-G","article-title":"Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defects","volume":"18","author":"Watt","year":"1998","journal-title":"Prenat Diagn."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110596_b0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pd.537","article-title":"Maternal serum marker medians in Aboriginal Canadian women","volume":"23","author":"Huang","year":"2003","journal-title":"Prenat Diagn."},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110596_b0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/pd.4313","article-title":"Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome","volume":"34","author":"Huttly","year":"2014","journal-title":"Prenat Diagn."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110596_b0205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/pd.2679","article-title":"Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetes","volume":"31","author":"Sprawka","year":"2011","journal-title":"Prenat Diagn."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110596_b0210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pd.895","article-title":"Should more ethnicity categories be used in multiple marker screening programmes?","volume":"24","author":"Liu","year":"2004","journal-title":"Prenat Diagn."},{"key":"10.1016\/j.clinbiochem.2023.110596_b0215","unstructured":"Government of Ontario. Collection of personal information. Standard 15. Race Categories. https:\/\/www.ontario.ca\/document\/data-standards-identification-and-monitoring-systemic-racism\/collection-personal-information. Accessed Nov 21 2022."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:10:40Z","timestamp":1762114240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912023001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"alternative-id":["S0009912023001248"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110596","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110596"}}